Published in Gene Therapy Weekly, October 18th, 2007
The Superhumanisation(TM) technology allows for modifying antibodies generated in animals so that they retain their essential therapeutic properties but appear "human-like" or "humanised" and will therefore not be rejected by the immune system of patients receiving them. Antibodies are the fastest growing class of drugs, with major product successes driving a continued high level of interest in this sector from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly